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CHIKV is a single stranded RNA arbovirus transmitted via mosquito vectors, specifically aedes aegypti and 
aedes albopictus (CDC, 2015).  Three genotypes classify the virus: Asian, West African, and 
Central/East/South African (Vega-Rúa et al, 2015).  The vectors live in warm, tropical climates and are also 
carriers for dengue virus.  Aedes aegypti and aedes albopictus are active during the day, with females biting 
several times during a feeding cycle (Weaver, Osorio, Livengood, Chen, & Stinchcomb. 2012).  According to 
Weaver, Osorio, Livengood, Chen, and Stinchcomb (2012), primates were initial hosts for CHIKV, but soon 
humans became infected.   
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Chikungunya means “that which 
bends up” in the Makonde language 
spoken in Tanzania and Mozambique 
(Halstead, 2015).  The tribe that gave 
CHIKV the current name is a short 24-
hour trip via modern travel from the 
United States. Ease of travel and global 
economy have brought CHIKV to areas 
that are not home to aedes aegypti and 
aedes albopictus. Health care providers 
must continue to educate themselves on 
emerging diseases such as CHIKV, for 
they are at the forefront of education, 
prevention, research, detection and 
treatment.  Who knows, the next case of 
CHIKV may be detected by you. 
Chikungunya fever is a viral infection caused by the Chikungunya virus (CHIKV).  Although seldom fatal, 
CHIKV causes high fevers, polyarthralgia, and rash.  The mosquito-borne virus has spread rapidly in the 
last ten years, causing over three million cases of CHIKV worldwide (Powers, 2015). The recent outbreak 
initiated in Africa and the islands of the Indian Ocean in 2004 has quickly spread to Asia, Europe and the 
Americas (CDC, 2015).  According to the CDC (2015), until 2014, cases in the United States had only been 
linked to foreign travel outside of the Americas.  As the outbreak has grown, cases of local transmission in 
Florida and Puerto Rico have necessitated increased education for healthcare clinicians in prevention, 
detection and treatment of CHIKV (Kendrick, Stanek, & Blackmore, 2014).  There is currently no antiviral 
treatment CHIKV or vaccine to prevent CHIKV (Weaver, Osorio, Livengood, Chen, & Stinchcomb, 2012). 
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Conclusion 
Nurses should be aware that CHIKV 
is transmitted from mosquitos in the 
United States (CDC, 2015).  The idea that 
CHIKV is isolated in Asia, Africa, and 
South America is outdated and 
dangerous.  Any patient that has 
traveled to tropical or temperate 
climates, where aedes aegypti and aedes 
albopictus are present, is at risk for 
developing CHIKV (CDC, 2015).  Health 
care providers should consider possible 
CHIKV transmission for any patient 
presenting with polyarthralgia, fever, 
and rash. 
 No vaccine 
or medication will prevent the disease at 
this time, but many steps can be taken to 
decrease the likelihood of contracting 
the virus (Prat et. al., 2014).  Nurses 
should instruct patients living or 
traveling in CHIKV outbreak locations on 
preventative measures.  People living or 
traveling in these areas should cover 
with long sleeve clothing when outside, 
use mosquito repellant with DEET, 
utilize air-conditioning if available, keep 
screens on doors and windows, and 
empty any standing water from 
containers (CDC, 2015).  If a patient 
develops signs of CHIKV, the patient 
should maintain strict avoidance of the 
mosquito vector in the first week (CDC, 
2015).  
Implications for  
Nursing Care 
CHIKV has rapidly spread 
throughout temperate and tropical 
climates around the world.  During the 
epidemic initiated in St. Martin with 
CHIKV Asian genotype in 2013, nearly 
one million people were infected 
throughout the Americas (Halstead, 
2015).  The need to develop rapid 
detection protocol and anticipate 
outbreaks before occurrence will lead to 
reduced infectivity (Prat et al., 2014).  
Primary prevention is currently 
protection of humans from exposure to 
mosquitos, but further prevention 
requires protecting humans ill with 
CHIKV from exposure to further 
mosquito bites (CDC, 2015). 
Significance of 
Pathophysiology 
• The two hallmark symptoms of 
CHIKV are fever and 
polyarthralgia effecting bilateral 
joints (Staples & Fischer, 2014)).   
• Symptoms also include headache, 
rash, muscle pain, and nausea 
and typically subside within two 
weeks (Harvey, 2015).    
• Foissac, Javelle, Ray, Guérin, and 
Simon (2015) report that two 
recent epidemics of CHIKV are 
known to cause post-
chikungunya rheumatoid 
arthritis.   
The author was first alerted to CHIKV during a trip abroad.  A poster depicting the CHIKV rash and CHIKV 
transmission information were presented in an international airport.  After many visits to East Africa and 
Central America, the author is interested in practicing in a foreign clinic where CHIKV is currently 
diagnosed in the population.  To many people in the regions affected by CHIKV, there are limited resources 
to healthcare, education, and nutrition.  Simple acts like mosquito nets, long sleeve shirts, and removal of 
stagnant water may keep food on the table for struggling families, kids in school, and medical facilities 
from overcrowding.  After initial research, it is evident that CHIKV could become a more widespread 
disease in the U.S. at any time.  With no vaccination available and symptom management as the only 
treatment, more work must be done to educate healthcare providers and define a detection and treatment 
plan with reliable outcomes around the world.   
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Table 1.  
Countries 
with reported 
local 
transmission 
of  
chikungunya 
virus disease 
(CDC, 2015) 
The transmission cycle is host-mosquito-host, meaning that an infected host is bitten by a vector whom then bites 
another host and deposits the infection (CDC, 2015).  CHIKV spreads rapidly in urban environments where the 
mosquito has multiple hosts in close proximity with high virulence (Sharp et al., 2014).  After transmission, the 
incubation period in the host is 3-7 days, with virus replication starting in the skin and traveling to the liver and 
joints through the blood stream (Weaver, Osorio, Livengood, Chen, & Stinchcomb. 2012).  CHIKV is detected 
through serum specimen by real-time reverse transcription-polymerase chain reaction (rPT-PCR) test within five 
days of symptom onset or IgM capture enzyme-linked immunosorbent assay (MAC-ELISA) at the sixth day and 
beyond (Sharp et. al., 2014).  Once a host is infected, protection from CHIKV with long-term immunity is noted 
(Sharp et al., 2014).  
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• Five percent of individuals suffering 
from CHIKV will suffer from post-
chikungunya rheumatoid arthritis 
lasting more than three months and 
experiencing pain and impaired 
mobility  
• (Foissac, Javelle, Ray, Guérin, & 
Simon, 2015).  Death occurs 
infrequently and has been reported 
in less than one percent of cases, 
most often plaguing older adults with 
comorbid conditions (Staples & 
Fischer, 2014). 
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